Literature DB >> 12376446

Squamous cell carcinomas of the head and neck.

R J Sanderson1, J A D Ironside.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12376446      PMCID： PMC1124330          DOI： 10.1136/bmj.325.7368.822

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

Review 1.  The burden of mouth cancer in Latin America and the Caribbean: epidemiologic issues.

Authors:  V Wünsch-Filho; E A de Camargo
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

Review 2.  Intensity modulated radiation therapy: a clinical review.

Authors:  C Nutting; D P Dearnaley; S Webb
Journal:  Br J Radiol       Date:  2000-05       Impact factor: 3.039

3.  a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer.

Authors:  F R Khuri; J Nemunaitis; I Ganly; J Arseneau; I F Tannock; L Romel; M Gore; J Ironside; R H MacDougall; C Heise; B Randlev; A M Gillenwater; P Bruso; S B Kaye; W K Hong; D H Kirn
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

4.  A prospective study of quality of life in head and neck cancer patients. Part I: at diagnosis.

Authors:  E Hammerlid; K Bjordal; M Ahlner-Elmqvist; M Boysen; J F Evensen; A Biörklund; M Jannert; S Kaasa; M Sullivan; T Westin
Journal:  Laryngoscope       Date:  2001-04       Impact factor: 3.325

Review 5.  The epidemiology of mouth cancer: a review of global incidence.

Authors:  S R Moore; N W Johnson; A M Pierce; D F Wilson
Journal:  Oral Dis       Date:  2000-03       Impact factor: 3.511

6.  Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes.

Authors:  K A Newkirk; K J Cullen; K W Harter; C A Picken; R B Sessions; B J Davidson
Journal:  Head Neck       Date:  2001-02       Impact factor: 3.147

7.  Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG).

Authors:  F Caponigro; E Massa; L Manzione; G Rosati; M Biglietto; L De Lucia; C Sguotti; P Sganga; A Avallone; P Comella; G Mantovani; G Comella
Journal:  Ann Oncol       Date:  2001-02       Impact factor: 32.976

Review 8.  Chemoprotective and radioprotective effects of amifostine: an update of clinical trials.

Authors:  R L Capizzi; W Oster
Journal:  Int J Hematol       Date:  2000-12       Impact factor: 2.490

9.  Organ preservation by transoral laser microsurgery in piriform sinus carcinoma.

Authors:  W Steiner; P Ambrosch; C F Hess; M Kron
Journal:  Otolaryngol Head Neck Surg       Date:  2001-01       Impact factor: 3.497

10.  Preliminary study of in vivo autofluorescence of nasopharyngeal carcinoma and normal tissue.

Authors:  J Y Qu; P Wing; Z Huang; D Kwong; J Sham; S L Lee; W K Ho; W I Wei
Journal:  Lasers Surg Med       Date:  2000       Impact factor: 4.025
View more
  79 in total

1.  Squamous cell carcinomas of the head and neck. Oral care for patients with cancer needs more than lip service.

Authors:  Vinod K Joshi
Journal:  BMJ       Date:  2003-02-01

2.  Risk stratification of oral cancer patients using a combined prognostic factor including lymph node density and biomarker.

Authors:  Ki-Yeol Kim; In-Ho Cha
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-23       Impact factor: 4.553

3.  Regulation of glycolysis in head and neck squamous cell carcinoma.

Authors:  Dhruv Kumar
Journal:  Postdoc J       Date:  2017-01

4.  Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT).

Authors:  Joanne W Chiu; Kelvin Chan; Eric X Chen; Lillian L Siu; Albiruni R Abdul Razak
Journal:  Invest New Drugs       Date:  2015-05-05       Impact factor: 3.850

5.  Gene-environment interactions associated with CYP1A1 MspI and GST polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population.

Authors:  Soya Sisy Sam; Vinod Thomas; K S Reddy; Gopalakrishnan Surianarayanan; Adithan Chandrasekaran
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-10       Impact factor: 4.553

6.  Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue.

Authors:  Murat Doğan; Sedat Çağlı; İmdat Yüce; Ali Bayram; Mehmet Akif Somdaş; Duran Karataş; Mehmet Celalettin Cihan; Fatih Yüksel; Ercihan Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-28       Impact factor: 2.503

7.  Silencing of Src by siRNA inhibits laryngeal carcinoma growth through the Src/PI-3 K/Akt pathway in vitro and in vivo.

Authors:  Yan Song; Yao-Dong Dong; Wei-Liang Bai; Xiu-Lan Ma
Journal:  Tumour Biol       Date:  2014-06-07

8.  Expression and clinical significance of microRNA-152 in supragalottic laryngeal carcinoma.

Authors:  Yan Song; Yuan Tian; Wei-Liang Bai; Xiu-Lan Ma
Journal:  Tumour Biol       Date:  2014-08-06

Review 9.  Genetic polymorphisms of matrix metalloproteinases and their inhibitors in potentially malignant and malignant lesions of the head and neck.

Authors:  Ajay Kumar Chaudhary; Mamta Singh; Alok C Bharti; Kamlesh Asotra; Shanthy Sundaram; Ravi Mehrotra
Journal:  J Biomed Sci       Date:  2010-02-15       Impact factor: 8.410

10.  Gene signatures of m5C regulators may predict prognoses of patients with head and neck squamous cell carcinoma.

Authors:  Miaomiao Xue; Qingmiao Shi; Lian Zheng; Qingbin Li; Liya Yang; Yuanyuan Zhang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.